Assessment of Reflex Urine Culture Criteria Changes and its Impact on Treatment of Asymptomatic Bacteriuria
Background. Asymptomatic bacteriuria (ASB) is a common clinical condition identified by the presence of bacteria in the urine of a patient without signs and symptoms of a urinary tract infection (UTI). Treatment of ASB leads to unnecessary antimicrobial use and can cause more harm than benefit in many patients. This study is to determine the impact of more stringent criteria for urinalysis with culture if indicated (UAC), implemented in September 2016, on the treatment of asymptomatic bacteriuria.
Methods. A pre-post descriptive study of patients was conducted with an order placed for UAC in the Emergency Department (ED) or hospital. Data was collected retrospectively via chart reviews. The data on ASB patients from November 2015 to April 2016 was compared with the post-implementation period October 2016 to January 2017. The number of UAC orders and cultures were averaged for 6 months pre and post implementation of the criteria change.
Results. A total of 580 patient charts were assessed post-implementation of the UAC criteria change. A majority of the orders originated from the ED, (N = 430, 72.8%). ASB was treated inappropriately at a rate of 60.4% (N = 64/106) pre-implementation and a rate of 65% (N = 41/63) post implementation, P = 0.542. The total number of UAC ordered before and after implementation did not change, (N = 2852 pre-intervention vs N = 2825 post-intervention, P = 0.744), as seen in Figure 1 . However, the number of reflexed urine cultures did significantly decrease post criteria change, (N = 1056 pre-intervention vs. N = 603 post-intervention, P < 0.0001). In addition, the number of positive urine cultures also significantly decreased, (N = 378 pre-intervention vs. N = 289 post-intervention, P = 0.0447). The impact the criteria change had on patient care is the number of potential antibiotic courses saved by reflexing fewer urine cultures off the UAC. Based on the decrease in positive urine cultures, it is estimated 702 courses of inappropriate antibiotics for ASB could be saved per year (59/month).
Conclusion. More stringent criteria for reflex urine cultures significantly decreases the number of urine cultures performed, therefore decreasing the number of patients treated with ASB. Additional stewardship measures are necessary to reduce the treatment of ASB for patients who have cultures performed. California, Davis Student Health Center (UCDSHC) has made prescribing NTF preferred for acute cystitis since 2001 as TMP/SMX has community resistance rates of ~20%. Ciprofloxacin is the second line agent at UCDSHC.
Methods. UCDSHC reviewed all urine cultures and susceptibilities for clinical and epidemiologic purposes. Susceptibility results were gathered from the UCDSHC microbiology laboratory from 2001-2016. Prescribing data was obtained from UCDSHC under diagnosis codes consistent with cystitis or UTI to demonstrate antibiotic prescribing trends. Susceptibilities were evaluated over the 15-year time period (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . TMP/SMX, FQ's, and NTF were the primary agents evaluated in this study.
Results. From 2001 From -2016 ,831 E. coli and 296 S. saprophyticus isolates were evaluated, accounting for 88% of the total number of organisms. E. coli susceptibilities to NTF remained >98% from 2001-2016. E. coli susceptibilities to FQ's trended down from 99% in 2001 to 88% in 2016. E. coli susceptibilities to TMP/SMX remained stable around 80% from 2001-2016. S. saprophyticusremained highly susceptible to NTF, FQ's, and TMP/SMX (95%, 97%, and 100% respectively at the end of the study period). In total, 12,298 prescriptions were written from . Eighty percent (9,875) were NTF and 17% (2,016) were FQ's. The remaining 1% and 2% were TMP/SMX and 'Other' , respectively.
Conclusion. After changes in prescribing practice in 2001, NTF was used in 80% of cystitis cases over 15 years and retained excellent activity against common urinary pathogens. FQ's retained acceptable activity for empiric use for urinary tract infections, but susceptibilities trended down notably despite limited FQ use. TMP/SMX did not regain increased activity over the time period.
Disclosures. All authors: No reported disclosures. Background. Urinary tract infection (UTI) is common among patients at Veterans Affairs Medical Centers (VAMCs), many of whom are elderly men with underlying medical or urological problems. Most UTI treatment guidelines address uncomplicated UTI in women and presume knowledge of local antimicrobial susceptibility testing (AST) patterns for uropathogens, which often are unknown or are inferred from E. coli. To inform selection of empiric therapy for UTI at our VAMC, we compiled AST data for one year's urine isolates.
Assessment of Antimicrobial Susceptibility Testing Profiles of Urine Isolates from Veterans to Guide Empiric Therapy for Suspected Urinary Tract Infection
Methods. We compiled AST results (bioMerieux VITEK®) for the 2,494 significant urine isolates from the Minneapolis VAMC clinical microbiology laboratory from June 2013 through May 2014. For "drug-bug" combinations that were not tested we imputed results based on local or published data, and/or expert opinion. We then calculated cumulative % susceptible for 25 relevant antimicrobial agents, overall and stratified by Gram stain group and clinical site (intensive care unit, inpatient, outpatient, community residential centers, or extended care). In ambiguous situations susceptibility was analyzed as both 0% and 100%.
Results. The 2,494 urine isolates included 946 Gram-positive and 1,548 Gramnegative organisms. Species distribution varied significantly by clinical site. E. coli represented only 27% of isolates overall (9-37%, depending on site). Enterococcus (14%) and other Gram-positives (23%) were also prevalent. Cumulative AST profiles varied significantly (i) by Gram stain group, (ii) between E. coli and other Gram-negatives, and (iii) by clinical site. No tested oral agent provided ≥ 80% overall susceptibility. Although AST data were unavailable for fosfomycin, imputation suggested 82%-95% susceptibility overall.
Conclusion. Among urine isolates from veterans, E. coli was a minor contributor and a poor surrogate for total population AST profiles. The only oral agent that provided ≥ 80% susceptibility overall was fosfomycin, suggesting that it could be an important option for empiric lower UTI therapy for veterans. Urine isolate-specific antibiograms that reflect local AST data, stratified by Gram stain group and clinical site, could improve empirical UTI therapy for veterans, as could performance of urine Gram stains. 
